Amplify Weight Loss Drug & Treatment ETF

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell THNR and other ETFs, options, and stocks.

About THNR

THNR tracks a modified market cap-weighted index of companies from developed markets that manufacture and enable GLP-1 agonist pharmaceutical businesses. 

Index-Tracked
VettaFi Weight Loss Drug & Treat TR USD
Index-TrackedVettaFi Weight Loss Drug & Treat TR USD
Category
Health
CategoryHealth
Number of holdings
27
Number of holdings27
Inception Date
May 20, 2024
Inception DateMay 20, 2024

What's in this fund

Sectors

As of April 10, 2025
Healthcare91.22%
Basic Materials4.96%
Consumer Defensive3.82%

Top 10 Holdings (70.14% of total assets)

As of April 10, 2025
NameSymbol% Assets
Eli LillyLLY15.49%
Novo NordiskNVO13.89%
Chugai Pharmaceutical Co Ltd4519 (XTKS)5.79%
West Pharmaceutical ServicesWST5.23%
AmgenAMGN5.17%
Innovent Biologics Inc01801 (XHKG)5.14%
Roche Holding AGROG (XSWX)4.88%
AstraZenecaAZN4.87%
PfizerPFE4.84%
Thermo Fisher ScientificTMO4.84%

THNR Key Statistics

AUM
3.53M
AUM3.53M
Price-Earnings ratio
25.30
Price-Earnings ratio25.30
30-Day yield
—
30-Day yield—
Average volume
1.53K
Average volume1.53K
High today
$19.26
High today$19.26
Low today
$19.26
Low today$19.26
Open price
$19.26
Open price$19.26
Volume
308.00
Volume308.00
52 Week high
$28.19
52 Week high$28.19
52 Week low
$18.56
52 Week low$18.56
Expense ratio
0.59
Expense ratio0.59
View Prospectus and Reports

Average Annual Return

All investments involve risks, including the loss of principal. Performance data represents past performance and is no guarantee of future results. Investment returns and principal value will fluctuate and are subject to market volatility. An investment, when redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance data quoted.